VACCINIA VIRUS POLYPEPTIDES
    31.
    发明申请

    公开(公告)号:US20120076810A1

    公开(公告)日:2012-03-29

    申请号:US13222862

    申请日:2011-08-31

    摘要: This document provides methods and materials related to polypeptides present in a vaccinia virus (e.g., polypeptides that can be isolated from naturally processed and presented class I polypeptides originating from vaccinia virus, a member of the Orthopoxvirus family). For example, methods for generating a vaccine comprising one or more of vaccinia virus polypeptides disclosed herein for preventing or treating Orthopoxvirus infection are provided. In addition, kits related to the use of vaccinia polypeptides are provided.

    摘要翻译: 本文件提供了与痘苗病毒中存在的多肽相关的方法和材料(例如可以从天然加工的和来源于痘苗病毒的I型多肽,正型疱疹病毒家族的成员分离的多肽)。 例如,提供了用于产生包含一种或多种本文公开的用于预防或治疗异痘病毒感染的痘苗病毒多肽的疫苗的方法。 此外,提供了与使用痘苗多肽有关的试剂盒。

    Method For Determining The Concentration of Virus Particles/Virus Antigens
    33.
    发明申请
    Method For Determining The Concentration of Virus Particles/Virus Antigens 审中-公开
    确定病毒颗粒/病毒抗原浓度的方法

    公开(公告)号:US20090202983A1

    公开(公告)日:2009-08-13

    申请号:US12087820

    申请日:2007-01-12

    申请人: Holger Kost

    发明人: Holger Kost

    IPC分类号: C12Q1/70

    摘要: The invention provides a method for determining the concentration of virus particles and/or virus antigens in a sample. In particular, the invention relates to determining the concentration of influenza virus particles/influenza virus antigens in a sample. The invention further relates to the use of an ion-exchange matrix for the determination of the concentration of virus particles and/or virus antigens in a sample.

    摘要翻译: 本发明提供了一种确定样品中病毒颗粒和/或病毒抗原浓度的方法。 特别地,本发明涉及确定样品中流感病毒颗粒/流感病毒抗原的浓度。 本发明还涉及离子交换基质用于测定样品中病毒颗粒和/或病毒抗原浓度的用途。